ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Fluorescent in-situ hybridization (FISH) and Polymerase Chain Reaction (PCR) are commonly employed to detect BCR-ABL fusion genes or transcripts, which are the distinctive biomarkers of CML [7,8].